Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
bio
biogen
biotech
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
general atlantic
gilead sciences
givosiran
google
google life sciences
government
greentech
health
What
deal
2
×
sciences
2
×
according
acquisitions
alphabet
announced
bio
ceo
collabs
company
continues
covid
daniel
detect
dictionary
disease
focus
gets
gilead
gilead’s
google
gotten
health
help
independent
introduce
ipo
itself
left
life
manage
means
medicines
moniker
month
new
news
o’day
plans
prevent
Language
unset
Current search:
deal
×
sciences
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@techcrunch.com
8 years ago
Alphabet Gets A “V” By Renaming Google Life Sciences To “Verily”